magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride

FDA Drug Profile — PRISMASOL B22GK4/0, PRISMASOL BGK4/0/1.2, PRISMASOL BGK2/0

magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride is listed in the FDA National Drug Code directory with 6 NDC codes, marketed under brand names including PRISMASOL B22GK4/0, PRISMASOL BGK4/0/1.2, PRISMASOL BGK2/0. Available dosage form: injection.

Drug details

Generic Name
magnesium chloride, dextrose anhydrous, lactic acid, sodium chloride, sodium bicarbonate, and potassium chloride
Brand Names
PRISMASOL B22GK4/0, PRISMASOL BGK4/0/1.2, PRISMASOL BGK2/0
Application Number
NDA021703
Sponsor
Vantive US Healthcare LLC
NDC Codes
6
Dosage Forms
INJECTION
Routes
INTRAVENOUS
Active Ingredients
ANHYDROUS DEXTROSE, LACTIC ACID, MAGNESIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE PRISMASOL and PHOXILLUM solutions are indicated in pediatric and adult patients for use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace plasma volume removed by ultrafiltration and to correct electrolyte and acid-base imbalances. They may also be used in case of drug poisoning when CRRT is used to remove dialyzable substances. PRISMASOL and PHOXILLUM solutions are indicated: • As a replacement solution in Continuous Renal Replacement Therapy (CRRT) and in case of drug poisoning when CRRT is used to remove dialyzable substances ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.